Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We have devised a strategy (called recombinase-mediated genomic replacement, RMGR) to allow the replacement of large segments (>100 kb) of the mouse genome with the equivalent human syntenic region. The technique involves modifying a mouse ES cell chromosome and a human BAC by inserting heterotypic lox sites to flank the proposed exchange interval and then using Cre recombinase to achieve segmental exchange. We have demonstrated the feasibility of this approach by replacing the mouse alpha globin regulatory domain with the human syntenic region and generating homozygous mice that produce only human alpha globin chains. Furthermore, modified ES cells can be used iteratively for functional studies, and here, as an example, we have used RMGR to produce an accurate mouse model of human alpha thalassemia. RMGR has general applicability and will overcome limitations inherent in current transgenic technology when studying the expression of human genes and modeling human genetic diseases.

Original publication

DOI

10.1016/j.cell.2006.11.044

Type

Journal article

Journal

Cell

Publication Date

12/01/2007

Volume

128

Pages

197 - 209

Keywords

Animals, Base Sequence, Chromosomes, Artificial, Bacterial, Chromosomes, Mammalian, Gene Targeting, Genetic Engineering, Genome, Globins, Hematologic Tests, Humans, In Situ Hybridization, Fluorescence, Mice, Mice, Transgenic, Regulatory Sequences, Nucleic Acid, Sequence Deletion, Synteny